Navigation Links
FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
Date:7/20/2009

novartis.com/" target="_new">http://www.novartis.com.

    Novartis US Media Contacts

    Kimberly Willard                      Anna Frable
    Novartis Pharmaceuticals Corporation  Novartis Pharmaceuticals Corporation
    862-778-4043 (office)                 862-778-5388 (office)
    973-727-3251 (mobile)                 732-673-5262 (mobile)
    kimberly.willard@novartis.com         anna.frable@novartis.com

    e-mail: media.relations@novartis.com

    Novartis Investor Relations

    Central phone:        +41 61 324 7944
    Ruth Metzler-Arnold   +41 61 324 9980  North America:
    Pierre-Michel Bringer +41 61 324 1065  Richard Jarvis  +1 212 830 2433
    John Gilardi          +41 61 324 3018  Jill Pozarek    +1 212 830 2445
    Thomas Hungerbuehler  +41 61 324 8425  Edwin Valeriano +1 212 830 2456
    Isabella Zinck        +41 61 324 7188

    e-mail: investor.relations@novartis.com

* Tekturna(R) is the US trade name for aliskiren. Aliskiren is known as Rasilez(R) outside the US.


'/>"/>
SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , Sept. 12, 2014 /PRNewswire-iReach/ -- 9 th ... 22-24, 2014 – Bethesda, MD ... http://www.fdanews.com/9thInspectionsSummitEarlyBird   Photo - http://photos.prnewswire.com/prnh/20140912/145652 ... for the next inspection than to get a glimpse ... during and after an inspection. Come to ...
(Date:9/12/2014)... DUBLIN , Sept. 12, 2014 ... addition of the "Global Medical Technologies Market ... Medical technology is a collective term for ... used to ensure good health. The Global Medical ... anaesthetic and respiratory technology, In vitro diagnostics technology, ...
(Date:9/12/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ... results from a health economic analysis suggesting that use ... in a significant reduction in direct medical costs and ... side effects of unnecessary treatment.  "By ... conventional measures, as demonstrated in this analysis, the Oncotype ...
Breaking Medicine Technology:FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 2Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 4Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 5
(Date:9/14/2014)... each night may mean you,re less likely to take time off ... study included more than 3,700 people in Finland, aged 30 to ... Those who slept less than six hours or more than nine ... from work due to illness, the investigators found. People with the ... were those who slept between seven and eight hours a night. ...
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable information for worldwide ... the site has announced that Arvixe ( http://www.arvixe.com/6883.html ... Hosting suppliers in the current market. , Arvixe ... provider, and the company’s reputation for reliability remains ... for its flexible hosting packages, decent uptime record ...
(Date:9/14/2014)... (PRWEB) September 14, 2014 A new DePuy ... Schulte LLC on behalf of a Franklin County, Ohio ... hip implant. The metal-on-metal hip lawsuit filed against Johnson ... the Ohio man was 40 years old when the Pinnacle ... No. 3:14-cv-02428-K) According to the hip implant lawsuit ...
(Date:9/14/2014)... Washington (PRWEB) September 14, 2014 School requires ... Washington law requires that they be screened only for far ... at twenty feet away. When their eyes do not ... their books, they will, at best, avoid reading; at ... brains and their ability to learn. Children who cannot ...
(Date:9/13/2014)... Recently, an experienced supplier of wedding dresses ... new collection of eggplant evening dresses . At ... rates, up to 58% off. According to the company’s ... 23. , The company’s new items are available ... plus size, modest, sexy outfits and so on. iFitDress.com ...
Breaking Medicine News(10 mins):Health News:A Good Night's Sleep May Mean a Good Day's Work 2Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 5Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2
... Safety Technology, HONOLULU, Aug. 5 ... Medical Center will equip 100 additional medical-surgical,floor ... Systems,(LifeBed), bringing the total number LifeBed,s available ... any bed into a LifeBed, which,invisibly tracks ...
... - Her Son May Need a Liver ... Transplant, ... come true. As she heads to the Mrs.,America* competition in Tucson, Arizona on ... her 10-year-old son, Connor will be,healthy again. Connor was born with a deadly ...
... Communication, Training and Disaster ... Preparedness ... a leading IP solutions provider offering telepresence and VoIP,services to business ... by St. Vincent Catholic Medical,Centers of New York for a variety ...
... First Half of 2008 Over 2007, WEST PALM ... MDF ), a leading provider of healthcare,services in ... quarter ended June 30, 2008., On July 28, ... ended,June 30, 2008, the company,s Medicare Advantage HMO and ...
... (NYSE: SCR ), a leading manufacturer and supplier ... biotech,product Endu in China, today reported unaudited financial results ... -- Total revenue increased to RMB436.2 million (US$63.6 ... representing a 30.4% year-over-year growth;, -- Net income ...
... $72 ... Million ... System Building Strong Market Momentum, ST. LOUIS, Aug. 5 Stereotaxis, Inc. ... for the recent second quarter increased 36% to $10.7,million compared with $7.8 million ...
Cached Medicine News:Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 3Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 2Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 3Health News:St. Vincent's Catholic Medical Centers of New York Select Telanetix Telepresence Solution 2Health News:St. Vincent's Catholic Medical Centers of New York Select Telanetix Telepresence Solution 3Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 2Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 3Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 4Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 5Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 6Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 7Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 8Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 9Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 2Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 3Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 4Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 5Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 6Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 7Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 8Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 9Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 11Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 12Health News:Stereotaxis Reports Record Second Quarter Revenue 2Health News:Stereotaxis Reports Record Second Quarter Revenue 3Health News:Stereotaxis Reports Record Second Quarter Revenue 4Health News:Stereotaxis Reports Record Second Quarter Revenue 5Health News:Stereotaxis Reports Record Second Quarter Revenue 6Health News:Stereotaxis Reports Record Second Quarter Revenue 7Health News:Stereotaxis Reports Record Second Quarter Revenue 8
...
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen....
... external ventricular drainage set (EVD ... fluid for external ventricular drainage. ... combination with a ventricular catheter ... 3XL probe from the Aesculap ...
... Bactiseal EVD Catheter system is ... catheter for external CSF drainage ... on catheter tube surfaces. Treated ... Impregnation Process, it reduces the ...
Medicine Products: